Soft Tissue Sarcoma: Relative Survival (%), Adults Aged , UK 1-Year

Slides:

Advertisements

Similar presentations

Age-Standardised One-, Five- and Ten-Year Net Survival, Selected Cancers, Adults (Aged 15-99), England and Wales, Five- and ten-year survival.

Advertisements

Sinus Cancer (C30, C31): One-, Five- and Ten-Year Net Survival (%), Adults Aged 15-90, England 1-Year 5-Year 10-Year Ad Hoc Sex Survival (%)

Ovarian Cancer (C56.9, C57.0-C57.4, C57.7):

Breast Cancer (C50): 2014 Number of New Cases, Crude and European Age-Standardised (AS) Incidence Rates per 100,000 Population, UK Northern England Wales.

Mesothelioma (C45): 2014 Number of New Cases, Crude and European Age-Standardised (AS) Incidence Rates per 100,000 Population, UK Northern England Wales.

All Cancers Excluding Non-Melanoma Skin Cancer (C00-C97 Excl

Hypopharyngeal Cancer (C12, C13):

Eye Cancer (C69): 2014 Number of New Cases, Crude and European Age-Standardised (AS) Incidence Rates per 100,000 Population, UK Northern England Wales.

Uterine Cancer (C54-C55): 2014 Number of New Cases, Crude and European Age-Standardised (AS) Incidence Rates per 100,000 Population, Females, UK Northern.

Colon Cancer (C18): Age-Standardised Five-Year Relative Survival, Adults (Aged 15+), European Countries Data consists of both observed and predicted.

Hodgkin Lymphoma Subtypes:

Pancreatic Cancer (C25):

Salivary Gland Cancer (C07, C08):

Cancer of Unknown Primary (C77-C80): 2013

Head & Neck Cancer (C00-C14, C30-C32): 2014

Prostate Cancer (C61): 2014 Number of New Cases, Crude and European Age-Standardised (AS) Incidence Rates per 100,000 Population, Males, UK Northern England.

Liver Cancer (C22): 2014 Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, UK Northern England Wales Scotland.

Kidney Cancer (C64-C66, C68): Age-Standardised Five-Year Relative Survival, Adults (Aged 15+), European Countries Data consists of both observed.

Age-Standardised Ten-Year Net Survival, Selected Cancers, Adults (Aged 15-99), England and Wales, Breast is for female only. Laryngeal is for.

Brain, Other CNS and Intracranial Tumours (C70-C72, C75. 1-C75

Thyroid Cancer (C73): One-, Five- and Ten-Year Net Survival (%), Adults Aged 15-90, England 1-Year 5-Year 10-Year Survival (%) Survival (%) Survival.

Age-Standardised Ten-Year Net Survival for the Most Common Cancers in Males, England and Wales, Ten-year survival for is predicted.

Gallbladder Cancer (C23-C24):

Uterine Cancer (C54-C55): 2014 Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, Females, UK Northern.

In Situ Breast Carcinoma (D05): 2014

Anal Cancer (C21): One-, Five- and Ten-Year Net Survival (%), Adults Aged 15-90, England 1-Year 5-Year 10-Year Survival (%) Survival (%) Survival.

Age-Standardised Ten-Year Net Survival for the Most Common Cancers in Females, England and Wales, Ten-year survival for is predicted.

Non-Melanoma Skin Cancer (C44): 2014

Hodgkin Lymphoma Subtypes:

Oral Cavity Cancer (C03, C04, C05, C06):

One-, Five- and Ten-Year Net Survival (%), Men, Aged 15-90, England

Lung Cancer (C33-C34): 2014 Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, UK Northern England Wales.

Kidney Cancer (C64-C66,C68): 2014 Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, UK Northern England.

Bone Sarcoma (C40-C41): 2014 Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, UK Northern England Wales.

per 100,000 Population, Females, UK

Malignant Melanoma (C43): 2014

Chronic Myeloid Leukaemia (C92.1): 2014

Oral Cancer (C00-C06,C09-C10,C12-C14): 2014

Hodgkin Lymphoma (C81): 2014 Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, UK Northern England Wales.

Bowel Cancer (C18-C20): 2014 Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, UK Northern England Wales.

Oesophageal Cancer (C15): 2014

Non-Hodgkin Lymphoma (C82-C86): 2014

Myeloma (C90): 2014 Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, UK Northern England Wales Scotland.

Chronic Lymphocytic Leukaemia (C91.1): 2014

All Children’s Cancers:

Tongue Cancer (C01, C02 excluding C02.4):

Acute Myeloid Leukaemia (C92. 0, C92. 4, C92. 5, C92. 6, C92. 8, C93

Stomach cancer Scotland, Patients diagnosed

Penile Cancer (C60): 2014 Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, Males, UK Northern England.

Bladder Cancer (C67): 2014 Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, UK Northern England Wales.

Anal Cancer (C21): 2014 Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, UK Northern England Wales Scotland.

Pancreatic Cancer (C25): 2014

per 100,000 Population, Females, UK

Eye Cancer (C69): 2014 Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, UK Northern England Wales Scotland.

Age-Standardised One-, Five- and Ten-Year Net Survival, Selected Cancers, Adults (Aged 15-99), England and Wales, Five- and ten-year survival.

Leukaemia (C91-C95): 2014 Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, UK Northern England Wales.

Acute Lymphoblastic Leukaemia (C91.0): 2014

Prostate Cancer (C61): 2014 Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, Males, UK Northern England.

Gallbladder Cancer (C23): 2014

Cancer of Unknown Primary (C77-C80): 2014

Oropharyngeal Cancer (C09, C10, C02.4):

Ovarian Cancer (C56-C57.4): 2014 Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, Females, UK Northern.

Vaginal or Vulval (C51-C52):

Breast Cancer (C50): 2014 Numbers of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, UK Northern England Scotland.

Stomach Cancer (C16): 2014 Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, UK Northern England Wales.

Thyroid Cancer (C73): 2014 Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, UK Northern England Wales.

Laryngeal Cancer (C32): 2014 Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, UK Northern England Wales.

Penile Cancer (C60): One-, Five- and Ten-Year Net Survival (%), Men, Aged 15-90, England 1-Year 5-Year 10-Year Survival (%) Survival (%) Survival.

All Cancers Excluding Non-Melanoma Skin Cancer (C00-C97 Excl

Bone Sarcoma (C40-C41): One-, Five- and Ten-Year Net Survival (%), Adults Aged 15-90, England 1-Year 5-Year 10-Year Survival (%) Survival (%)

Presentation transcript:

Soft Tissue Sarcoma: 1996-2000 Relative Survival (%), Adults Aged 15-85+, UK 1-Year 5-Year 10-Year Survival (%) Survival (%) Survival (%) Ad Hoc Sex (2005-2009) (2001-2005) (1996-2000) Relative survival 77.0 55.0 46.0 Men 95% LCL 76.0 54.0 44.0 95% UCL 78.0 57.0 48.0 Relative survival 73.0 52.0 43.0 Women 95% LCL 72.0 51.0 42.0 95% UCL 74.0 53.0 45.0 Relative survival 75.0 53.0 45.0 Adults 95% LCL 74.0 52.0 43.0 95% UCL 76.0 54.0 46.0 95% LCL and 95% UCL are the 95% lower and upper confidence limits Five- and ten-year survival is predicted using an excess hazard statistical model Source: cruk.org/cancerstats You are welcome to reuse this Cancer Research UK statistics content for your own work. Credit us as authors by referencing Cancer Research UK as the primary source. Suggested style: Cancer Research UK, full URL of the page, Accessed [month] [year].